About us

Our Vision: Regenerative medicine has the potential to improve the quality of life of every person.

Feldan Therapeutics_website


Cell therapy is the next frontier in modern medicine, with its huge potential for curing and treating diseases. Cell therapy uses living cells as treatment. Moreover, the more recently developed genome editing technologies allow for genetically modified stem cells thereby pushing even further the limits of cells as therapeutic treatment. Together cell therapy and gene-modified cell therapy have the potential to drastically change the standards of care and redefine quality of life.

However, the technologies needed to translate genome modifications and transcription factors into medical applications are still limited and currently only rely on the use of viruses and electroporation. While effective in certain cell types, these techniques have proven to affect cell viability, to decrease cell potency and to pose safety and regulatory issues. Feldan has developed the Feldan Shuttle, a protein-based technology platform that directly delivers proteins – such as nucleases or transcription factors – inside cells and to specific cellular compartments. Feldan Shuttle can overcome major obstacles faced by nucleic acid delivery for therapeutic use by considerably decreasing the regulatory burden and by accelerating the translation of discoveries into clinical applications. Feldan Shuttle enables efficiency and flexibility that will be leveraged through the development of new therapies.

Background-home_Feldan_Our history
Inception and expertise

Feldan is a leader in the field of recombinant protein production. Since its foundation in 2007, Feldan is profoundly engaged in the discovery, development, manufacturing and marketing of recombinant proteins designed to address research needs in life science. The company has been producing recombinant proteins and molecular biology reagents for life science companies and research laboratories around the world. Through these business opportunities, Feldan has acquired a high expertise in recombinant protein production and a solid track record in hard-to-produce recombinant proteins using either bacterial, yeast or mammalian expression systems. Feldan has also developed technical skills in medium scale production and in regulated production environment.

Focus on Cell therapy

At the end of 2012, Feldan has decided to focus its core expertise towards the development and production of ancillary material for the regenerative medicine industry. This new orientation is a direct application of Feldan’s know-how in the production of high-quality recombinant proteins. This expertise allows Feldan to offer top-of-the-line proteins that are fully adapted to the needs of cell therapy developers.

Development of the Feldan Shuttle

Since its beginning, Feldan has always valued internal research as an engine to generate value; with the development of the Feldan Shuttle in the later years, this vision is now coming true. The scientists at Feldan have uncovered a disruptive technology that allows the transition of protein-based therapies toward clinical trials. Along with the protein production platform, the Shuttle now allows Feldan to develop medical applications in-house as well as in collaboration with partners. This novel direction comes along with a new name (Feldan Therapeutics) and hints the multiple possibilities that lay ahead.


To succeed in a business environment filled with challenges and ongoing changes, we must remember who we are. Our core values are what makes Feldan unique. Acting in accordance with our values keeps us on the right path, and will continually increase the strength of our company. Feldan’s actions and decision-making is guided by Our Values in different situations and enable achievement of our mission.


We are owner of Feldan’s future. We stake our reputation on the excellence of our work and accept accountability to meet our business needs, improve our systems and help others improve their effectiveness. We are Feldan.


We mobilize our resources in order to promote optimal efficiency and performance in all our business activities. We take pride in having a highly diverse team of people with complementary backgrounds, the union of which makes us a unique, disruptive and innovative company.

We believe having fun and enjoying our work is essential to achieve our mission, we celebrate successes and we have fun working together.